Fish Oil and Biomarkers of Cardiovascular Risk

Stopped early · Not applicable · Has a placebo group

Conditions studied: Cardiovascular Risk Factors

In brief

Rationale Experimental data indicate an inverse relation between intake of omega-3 fatty acids ('fish oil'), primarily in the form of eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), and risk of developing cardiovascular disease in healthy adults. Mechanisms underlying this cardioprotective effect are unknown but may involve favorable influences on various biomarkers of cardiovascular risk. In this project we will determine if these favorable effects of omega-3's occur in older healthy adults, as aging is a primary risk factor for cardiovascular disease development. Key Objectives To determine the effect of chronic (12 week) oral omega-3 fatty acid supplementation on biomarkers of cardiovascular risk in young and older adults. We hypothesize that omega-3 fatty acid supplementation will exert positive effects on biomarkers of cardiovascular risk. Study Population Healthy young (18-40 years of age) and older (50-79) men and women. Major Inclusion \& Exclusion Criteria Subjects must be healthy (as assessed by history and physical examination: non obese BMI\<30: normotensive BP \<140/90 mmHg) men and women not currently taking medications that could influence the results. Women must be non-pregnant. Normal liver enzymes (ALT and AST). Individuals with allergies to corn will be excluded. Allocation to Groups Randomized, double-blinded, and placebo-controlled. Summary of Procedures Measurements will be made at baseline and repeated \~12 weeks after beginning daily oral ingestion of either low dose or high dose fish oil capsules or placebo

Key facts

Study ID: NCT00527436
Run by: Milton S. Hershey Medical Center
People needed: 3
Starts: 2007-09-01
Expected to finish: 2007-09-01
Last updated by the study team: 2019-04-10

Who can join

Age: 20 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subjects must be healthy (as assessed by history and physical examination:
Non obese BMI<30: normotensive BP <140/90 mmHg) men and women not currently taking medications that could influence the results.
Women must be non-pregnant.
Normal liver enzymes (ALT and AST).

You may not qualify if…

Individuals with allergies to corn will be excluded.

Where it is running

Penn State College of Medicine — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.